Has participated in:
-
Ein bispezifisches modulares Antikörpersystem zur T-Zell-basierten Immuntherapie der Akuten Myeloischen Leukämie und des Prostatakarzinoms
-
RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma
-
Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment
-
64 Cu tumor labeling with hexadentate picolinic acid‐based bispidine immunoconjugates